Rhumbline Advisers Chroma Dex Corp. Transaction History

Rhumbline Advisers

$109 Billion
Q3 2024

A detailed history of Rhumbline Advisers transactions in Chroma Dex Corp. stock. As of the latest transaction made, Rhumbline Advisers holds 41,156 shares of CDXC stock, worth $307,023. This represents 0.0% of its overall portfolio holdings.

Number of Shares

41,156

Previous 45,519 9.59%

Holding current value

$307,023

Previous $124,000 20.97%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$2.51 - $3.8 $10,951 - $16,579	-4,363 Reduced 9.59%	41,156 $150,000
Q2 2024 Aug 01, 2024	BUY	$2.44 - $4.32 $111,066 - $196,642	45,519 New	45,519 $124,000
Q2 2022 Aug 11, 2022	SELL	$1.59 - $2.7 $74,807 - $127,032	-47,049 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$2.02 - $3.92 $1,292 - $2,508	640 Added 1.38%	47,049 $116,000
Q4 2021 Feb 10, 2022	SELL	$3.74 - $6.7 $1,294 - $2,318	-346 Reduced 0.74%	46,409 $174,000
Q3 2021 Nov 12, 2021	BUY	$6.05 - $10.41 $9,982 - $17,176	1,650 Added 3.66%	46,755 $293,000
Q2 2021 Aug 05, 2021	SELL	$6.66 - $10.92 $7,932 - $13,005	-1,191 Reduced 2.57%	45,105 $445,000
Q1 2021 May 06, 2021	SELL	$4.59 - $18.74 $5,783 - $23,612	-1,260 Reduced 2.65%	46,296 $432,000
Q4 2020 Feb 10, 2021	BUY	$3.93 - $5.5 $11,907 - $16,665	3,030 Added 6.81%	47,556 $228,000
Q3 2020 Nov 12, 2020	SELL	$4.01 - $5.56 $28,190 - $39,086	-7,030 Reduced 13.64%	44,526 $179,000
Q2 2020 Aug 13, 2020	BUY	$3.0 - $5.52 $11,016 - $20,269	3,672 Added 7.67%	51,556 $237,000
Q4 2019 Feb 05, 2020	BUY	$2.83 - $4.61 $274 - $447	97 Added 0.2%	47,884 $206,000
Q3 2019 Oct 23, 2019	SELL	$3.83 - $4.72 $57 - $70	-15 Reduced 0.03%	47,787 $188,000
Q2 2019 Aug 14, 2019	BUY	$3.71 - $4.83 $1,135 - $1,477	306 Added 0.64%	47,802 $222,000
Q1 2019 May 01, 2019	SELL	$3.2 - $4.19 $3,248 - $4,252	-1,015 Reduced 2.09%	47,496 $199,000
Q4 2018 Jan 31, 2019	BUY	$2.8 - $4.22 $47,216 - $71,161	16,863 Added 53.28%	48,511 $166,000
Q3 2018 Nov 07, 2018	SELL	$3.5 - $4.91 $1,022 - $1,433	-292 Reduced 0.91%	31,648 $136,000
Q2 2018 Aug 06, 2018	BUY	$3.22 - $4.43 $102,846 - $141,494	31,940 New	31,940 $118,000

Others Institutions Holding CDXC

# of Institutions

Shares Held

17.2M

Call Options Held

66.7K

Put Options Held

8.2K

View Full List

About ChromaDex Corp.

Ticker CDXC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,350,896
Market Cap $510M
Description
ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...

More about CDXC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account

Rhumbline Advisers Chroma Dex Corp. Transaction History